GENE ONLINE|News &
Opinion
Blog

Nasal Spray
Asia-Pacific AnxietyPhase 3 Trial
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
Trials & Approvals Overdose
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Trials & Approvals Migraine
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Technology FDA
First Nasal Spray for Allergies Now Available Over-the-Counter
2022-07-13
Funding COVID-19
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Trials & Approvals Nasal Spray
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
Trials & Approvals Depression
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top